MS
AMED

Maven Securities’s Amedisys AMED Stock Holding History

Maven Securities’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,000
Closed -$473K – 795
2025
Q1 		$463K Sell
5,000
-31,600
-86% -$2.91M 0.01% 614
2024
Q4 		$3.32M Buy
36,600
+16,349
+81% +$1.5M 0.08% 200
2024
Q3 		$1.95M Sell
20,251
-6,767
-25% -$660K 0.04% 354
2024
Q2 		$2.48M Buy
+27,018
New +$2.51M 0.06% 325

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Maven Securities's AMED Position: Q2 2025 in Review

Maven Securities sold out of Amedisys (AMED) in Q2 2025, closing a stake of 5,000 shares — an estimated $473K sold.

Maven Securities first reported a position in AMED in Q2 2024 and held it in 4 quarters. The position peaked at $3.32M in Q4 2024. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • Maven Securities reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • Maven Securities sold 5,000 Amedisys shares in Q2 2025, an estimated $473K.
  • Maven Securities first reported a position in Amedisys in Q2 2024 and held it in 4 quarters.
  • Maven Securities's Amedisys position peaked at $3.32M in Q4 2024.
  • 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Maven Securities's 13F filing for Q2 2025, filed 14 Aug 2025.